<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-955
Date of Submission: 2025-01-01

This report was submitted by a Other Healthcare Professional from Garcia-Hart Medical Center concerning patient ANON-PX-5820. The subject is an adult female with a significant medical history including coronary artery disease, hypertension. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Sertraline (SSRI) administered via the Intravenous route at a dosage of 199mg, initiated on 2024-10-31 for Major depressive disorder with the course ongoing; Ibuprofen (NSAID) administered via the Intramuscular route at a dosage of 40mg, initiated on 2024-10-31 for Pain and inflammation with the course ongoing.

On approximately 2024-11-30, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Dizziness, Anaphylaxis, Hepatotoxicity. The Dizziness was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed bar and advised business. The current patient status regarding this symptom is 'Recovered'. The Anaphylaxis was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. The Hepatotoxicity was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 9 was calculated, The assessment concluded the relationship was 'Highly Probable'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Hotel central value. Name somebody attention all job keep act. Name executive tonight focus edge toward discover.</data>
report_id: ADR-2025-955
report_date: '2025-01-01'
patient_details:
  patient_id: ANON-PX-5820
  gender: Female
  relevant_history:
  - coronary artery disease
  - hypertension
suspected_drugs:
- drug_name: Sertraline
  dosage: 199mg
  route_of_administration: Intravenous
  start_date: '2024-10-31'
  indication_for_use: Major depressive disorder
  drug_class: SSRI
- drug_name: Ibuprofen
  dosage: 40mg
  route_of_administration: Intramuscular
  start_date: '2024-10-31'
  indication_for_use: Pain and inflammation
  drug_class: NSAID
adverse_reactions:
- symptom_name: Dizziness
  onset_date: '2024-11-30'
  severity: Mild
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed bar and advised business.
- symptom_name: Anaphylaxis
  onset_date: '2024-11-30'
  severity: Moderate
  outcome: Recovering
  intervention_required: false
- symptom_name: Hepatotoxicity
  onset_date: '2024-11-30'
  severity: Moderate
  outcome: Unknown
  intervention_required: false
causality_assessment:
  assessment_conclusion: Highly Probable
  dechallenge_rechallenge: Negative dechallenge
  naranjo_score: 9
reporting_facility: Garcia-Hart Medical Center
reporter_type: Other Healthcare Professional
notes: Hotel central value. Name somebody attention all job keep act. Name executive
  tonight focus edge toward discover.
